The Carbapanem-resistant Acinetobacter baumannii (CRAB) is classified as a priority 1 pathogen by the WHO, designed by Roche Pharma Research in Basel, Switzerland, Zosurabalin defeated strains of CRAB-induced pneumonia and sepsis in mouse models.